Advertisement

Reata Pharmaceuticals, Inc. RETA

Set alert

Price alert · RETA

All alert types
172.36 +172.36 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
4.04B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-22.49
Beta
1.37
Short ratio
5.10
Inst. own
101.73%
Dividend
0.00
Ex-div date
Earnings
Nov 14, 2023
50-d avg
95.35
200-d avg
62.81
1y target
115.30

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for RETA has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Other Income → Gross Profit & Other Income: $274.20MGross Profit & Other Income → Net Income: $193.00MGross Profit & Other Income → Selling, General & Admin: $45.69MGross Profit & Other Income → Research & Development: $57.12MGross Profit & Other Income → Other Operating Expenses: $293.00KProduct → Revenue: $20.04MGross Profit → Gross Profit & Other Income: $21.90MRevenue → Gross Profit: $21.90MRevenue → Cost of Revenue: $846.00KService, Other → Revenue: $2.71MOther Income$274.20MGross Profit$21.90MCost of Revenue$846.00KGross Profit & Other Income$296.10MNet Income$193.00MSelling, General & Admin$45.69MResearch & Development$57.12MOther Operating Expenses$293.00KRevenue$22.75MProduct$20.04MService, Other$2.71M

Period ending Jun 30, 2023 · select a line to chart its history

Income statement

RETA quarterly income statement
22.75M
22.75M
846.00K
21.90M
114.10M
57.12M
45.69M
-92.20M
-285.20M
193.00M
193.00M
193.00M
193.00M
5.12
5.12
4.65
-92.20M
-92.20M
37.67M
41.51M

Balance sheet

RETA quarterly balance sheet
48.84M
48.84M
281.37M
281.37M
22.66M
401.85M
89.90M
502.59M
2.46M
166.00M
125.09M
163.55M
415.30M
-1.49B
87.29M
87.29M
100.74M
166.00M
13.28M
290.20M
19.86M

Cash flow

RETA quarterly cash flow
293.00K
76.78M
-36.10M
-274.00K
795.00K
72.17M
-42.95M
-42.67M
-69.93M
20.36M
Advertisement